Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770675809481 Cache Key: cqdTagPageBySlug:car-t-cell-therapy fetchCache[cqdTagPageBySlug:car-t-cell-therapy].expirationTime: falsey fetchCache[cqdTagPageBySlug:car-t-cell-therapy]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: -95634 -- Key: cqdTagPageBySlug:john-greskovich, seconds remaining: -109239 -- Key: cqdPostsByTag:cqd-migrated-tag-750,1,10, seconds remaining: -109151 -- Key: cqdTagPageBySlug:asrm-2016, seconds remaining: -107568 -- Key: cqdPostsByTag:cqd-migrated-tag-4783,1,10, seconds remaining: -107496 -- Key: cqdTagPageBySlug:hyperthermia, seconds remaining: -107109 -- Key: cqdPostsByTag:cqd-migrated-tag-104,1,10, seconds remaining: -107036 -- Key: cqdTagPageBySlug:cost-efficiency, seconds remaining: -106616 -- Key: cqdPostsByTag:cqd-migrated-tag-18167,1,10, seconds remaining: -106417 -- Key: cqdTagPageBySlug:photodocumentation-system, seconds remaining: -106176 -- Key: cqdPostsByTag:cqd-migrated-tag-16908,1,10, seconds remaining: -106115 -- Key: cqdTagPageBySlug:bleeding-emergencies, seconds remaining: -105309 -- Key: cqdPostsByTag:cqd-migrated-tag-20282,1,10, seconds remaining: -105227 -- Key: cqdTagPageBySlug:pitolisant, seconds remaining: -104825 -- Key: cqdPostsByTag:cqd-migrated-tag-26315,1,10, seconds remaining: -104755 -- Key: cqdTagPageBySlug:agile, seconds remaining: -95634 -- Key: cqdPostsByTag:cqd-migrated-tag-23959,1,10, seconds remaining: -95557 -- Key: cqdTagPageBySlug:single-sided-deafness, seconds remaining: -95170 -- Key: cqdPostsByTag:cqd-migrated-tag-24040,1,10, seconds remaining: -95091 -- Key: cqdTagPageBySlug:ehr-2, seconds remaining: -94745 -- Key: cqdPostsByTag:cqd-migrated-tag-24249,1,10, seconds remaining: -94668 -- Key: cqdTagPageBySlug:paxlovid, seconds remaining: -93873 -- Key: cqdPostsByTag:cqd-migrated-tag-26184,1,10, seconds remaining: -93803 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:car-t-cell-therapy - retrieving from Sanity CCCache.dataFetchCount: 36 Cache cleanup seconds remaining: 30000
Advertisement
Advertisement
Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy
Distinct baseline immune profiles can predict response and resistance to different types of CAR-T cells.
Patient achieves complete remission from aggressive marginal zone lymphoma with liso-cel
A conversation with Marcelo Pasquini, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Early results show patients experiencing deep and complete response
Discussing research into improving CAR T-cell therapy efficacy
Making sense of the fast-moving treatment landscape
CAR T-cell therapy may offer reason for optimism that those with SLE can experience improvement in quality of life.
Explaining common misconceptions about chimeric antigen receptor therapy
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
Rendered: Mon Feb 09 2026 22:23:29 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.
Search
